Peptide safety profile Preclinical research on BPC-157 safety is relatively encouraging
Indeed, hydrochlorothiazide gained widespread popularity following a controlled trial for the management of hypertension published in 1970 (Collins et al., 1990
Is there a neuroendocrinological rationale for testosterone as a therapeutic option in depression
10.1182/blood.v94.11.3906 86 Two Gene Therapies for Sickle Cell Disease (2024)
Weight of evidence: Overall evidence is Low-Moderate: multiple animal studies and a growing number of small clinical trials suggest benefits across gutbrain signaling, social and behavioral domains, gastrointestinal symptoms, and neurophysiological patterns, yet most human studies rely on caregiver-reported outcomes, lack biomarker integration, and seldom control for diet, comorbidities, or baseline microbiome composition